SLC18A1 and Parkinson disease: Cross-validating all these interactions with the KEGG PD schematic (Fig. 1), it can now be implied that SLC18A1 dysfunction directly leads to SNCA dysfunction at the transcription level and could potentially promote DA toxicity and impaired neurotransmission, leaving dopaminergic neurons vulnerable to damage at the protein level.